Aperion Biologics' Series D Round

Aperion Biologics raised a round of funding on May 31, 2011.

Aperion Biologics is a clinical-stage medical device company addressing the need for alternatives to human-based grafts with patented animal based tissue. Aperion Biologics has developed and patented …

Articles about Aperion Biologics' Series D Round: